Otsuka Hits Indian Pharma Co. With IP Suit Over Kidney Drug
By Britain Eakin · June 24, 2021, 5:59 PM EDT
Otsuka Pharmaceutical Co. has sued Indian drug manufacturer Lupin for patent infringement over a planned generic version of Otsuka's kidney treatment drug Jynarque, which is used to treat patients suffering from...
To view the full article, register now.